- call +1-201-465-4211
- email sales@mrinsights.biz
Sexually transmitted diseases (STDs), also referred as venereal diseases are infections that can pass from person to person during sex. These diseases are caused mainly due to bacteria, viruses, and / or parasites. Sexually transmitted diseases (STDs) often go undiagnosed because these infections usually do not exhibit visual symptoms.
Scope of the Report:
This report focuses on the Sexually Transmitted Disease (STD ) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Sexually Transmitted Disease (STD ) Drug is expected to grow at a CAGR of roughly 10.4% over the next five years, will reach 25800 million US$ in 2023, from 14300 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer
Roche
Bayer
Eli Lilly
Johnson & Johnson
Bristol-Myers Squibb
AbbVie
Gilead Sciences
GlaxoSmithKline
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibiotics
Antiviral
Vaccines
Market Segment by Applications, can be divided into
Hospital
Clinic
There are 15 Chapters to deeply display the global Sexually Transmitted Disease (STD ) Drug market.
Chapter 1, to describe Sexually Transmitted Disease (STD ) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Sexually Transmitted Disease (STD ) Drug, with sales, revenue, and price of Sexually Transmitted Disease (STD ) Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Sexually Transmitted Disease (STD ) Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Sexually Transmitted Disease (STD ) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Sexually Transmitted Disease (STD ) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Sexually Transmitted Disease (STD ) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Antibiotics
1.2.2 Antiviral
1.2.3 Vaccines
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Sexually Transmitted Disease (STD ) Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Sexually Transmitted Disease (STD ) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Sexually Transmitted Disease (STD ) Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Sexually Transmitted Disease (STD ) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Sexually Transmitted Disease (STD ) Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Sexually Transmitted Disease (STD ) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Sexually Transmitted Disease (STD ) Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Sexually Transmitted Disease (STD ) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Sexually Transmitted Disease (STD ) Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb
2.6.1 Business Overview
2.6.2 Sexually Transmitted Disease (STD ) Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 AbbVie
2.7.1 Business Overview
2.7.2 Sexually Transmitted Disease (STD ) Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AbbVie Sexually Transmitted Disease (STD ) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Gilead Sciences
2.8.1 Business Overview
2.8.2 Sexually Transmitted Disease (STD ) Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Gilead Sciences Sexually Transmitted Disease (STD ) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 GlaxoSmithKline
2.9.1 Business Overview
2.9.2 Sexually Transmitted Disease (STD ) Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck
2.10.1 Business Overview
2.10.2 Sexually Transmitted Disease (STD ) Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck Sexually Transmitted Disease (STD ) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Sexually Transmitted Disease (STD ) Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Sexually Transmitted Disease (STD ) Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Sexually Transmitted Disease (STD ) Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Sexually Transmitted Disease (STD ) Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Sexually Transmitted Disease (STD ) Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Sexually Transmitted Disease (STD ) Drug Market Analysis by Regions
4.1 Global Sexually Transmitted Disease (STD ) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Sexually Transmitted Disease (STD ) Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Sexually Transmitted Disease (STD ) Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
4.3 Europe Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
4.5 South America Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
5 North America Sexually Transmitted Disease (STD ) Drug by Countries
5.1 North America Sexually Transmitted Disease (STD ) Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Sexually Transmitted Disease (STD ) Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Sexually Transmitted Disease (STD ) Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
5.3 Canada Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
6 Europe Sexually Transmitted Disease (STD ) Drug by Countries
6.1 Europe Sexually Transmitted Disease (STD ) Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Sexually Transmitted Disease (STD ) Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Sexually Transmitted Disease (STD ) Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
6.3 UK Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
6.4 France Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
6.5 Russia Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
6.6 Italy Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Sexually Transmitted Disease (STD ) Drug by Countries
7.1 Asia-Pacific Sexually Transmitted Disease (STD ) Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Sexually Transmitted Disease (STD ) Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Sexually Transmitted Disease (STD ) Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
7.3 Japan Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
7.4 Korea Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
7.5 India Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
8 South America Sexually Transmitted Disease (STD ) Drug by Countries
8.1 South America Sexually Transmitted Disease (STD ) Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Sexually Transmitted Disease (STD ) Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Sexually Transmitted Disease (STD ) Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Sexually Transmitted Disease (STD ) Drug by Countries
9.1 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
9.3 UAE Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Sexually Transmitted Disease (STD ) Drug Sales and Growth Rate (2013-2018)
10 Global Sexually Transmitted Disease (STD ) Drug Market Segment by Type
10.1 Global Sexually Transmitted Disease (STD ) Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Sexually Transmitted Disease (STD ) Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Sexually Transmitted Disease (STD ) Drug Revenue and Market Share by Type (2013-2018)
10.2 Antibiotics Sales Growth and Price
10.2.1 Global Antibiotics Sales Growth (2013-2018)
10.2.2 Global Antibiotics Price (2013-2018)
10.3 Antiviral Sales Growth and Price
10.3.1 Global Antiviral Sales Growth (2013-2018)
10.3.2 Global Antiviral Price (2013-2018)
10.4 Vaccines Sales Growth and Price
10.4.1 Global Vaccines Sales Growth (2013-2018)
10.4.2 Global Vaccines Price (2013-2018)
11 Global Sexually Transmitted Disease (STD ) Drug Market Segment by Application
11.1 Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
12 Sexually Transmitted Disease (STD ) Drug Market Forecast (2018-2023)
12.1 Global Sexually Transmitted Disease (STD ) Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Sexually Transmitted Disease (STD ) Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Sexually Transmitted Disease (STD ) Drug Market Forecast (2018-2023)
12.2.2 Europe Sexually Transmitted Disease (STD ) Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Sexually Transmitted Disease (STD ) Drug Market Forecast (2018-2023)
12.2.4 South America Sexually Transmitted Disease (STD ) Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Forecast (2018-2023)
12.3 Sexually Transmitted Disease (STD ) Drug Market Forecast by Type (2018-2023)
12.3.1 Global Sexually Transmitted Disease (STD ) Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Sexually Transmitted Disease (STD ) Drug Market Share Forecast by Type (2018-2023)
12.4 Sexually Transmitted Disease (STD ) Drug Market Forecast by Application (2018-2023)
12.4.1 Global Sexually Transmitted Disease (STD ) Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Sexually Transmitted Disease (STD ) Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Sexually Transmitted Disease (STD ) Drug Picture
Table Product Specifications of Sexually Transmitted Disease (STD ) Drug
Figure Global Sales Market Share of Sexuall
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
